Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Infectious Diseases

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/314522PMID 9815240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CCR2 polymorphism and HIV disease. Swiss HIV Cohort.

  1998cited by this paper
• Gene organization and promoter function for CC chemokine receptor 5 (CCR5).

  1998cited by this paper
• A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation

  1998cited by this paper
• Chemokine receptors and the clinical course of HIV-1 infection.

  1998cited by this paper
• CCR2 Polymorphism and HIV Disease

  1998cited by this paper
• In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression

  1997cited by this paper
• Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals

  1997cited by this paper
• Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

  1997influential reference
• The Human CC Chemokine Receptor 5 (CCR5) Gene

  1997cited by this paper
• Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

  1997cited by this paper
• Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

  1996cited by this paper
• Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research.

  1996cited by this paper
• Chemokines and HIV–1 second receptors

  1996cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• HIV‐1 biological phenotype in long‐term infected individuals evaluated with an MT‐2 cocultivation assay

  1992cited by this paper
• Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men.

  1989cited by this paper
• Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases.

  1987cited by this paper

• Severity-onset prediction of COVID-19 via artificial-intelligence analysis of multivariate factors

  2023cites this paper
• Risk assessment of progression to severe conditions for patients with COVID-19 pneumonia: a single-center retrospective study

  2020cites this paper
• A Simultaneous Safety Analysis of Crash Frequency and Severity for Highway-Rail Grade Crossings: The Competing Risks Method

  2020cites this paper
• Neuropathogenesis of human immunodeficiency virus infection.

  2018cites this paper
• after commencing therapy in HIV patients from countries where

  2018cites this paper
• Frequency of MCP-1 (rs1024611) and CCR2 (rs1799864) gene polymorphisms and its effect on gene expression level in patients with AgP.

  2017cites this paper
• The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

  2015cites this paper
• Investigation into the hepatotoxic effects of Highly Active Anti-Retroviral Therapy (HAART) medications

  2014cites this paper
• Genetic variation and HIV-associated neurologic disease.

  2013cites this paper
• The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression

  2013cites this paper
• Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics

  2012cites this paper
• Single Nucleotide Polymorphism in Gene Encoding Transcription Factor Prep1 Is Associated with HIV-1-Associated Dementia

  2012cites this paper
• The Distribution of CCR2-64I, SDF1-3′A and MCP1-2518 G/A Genes Polymorphism in a Specific High Risk Group from the Northeastern States West Bengal, and Gorkha Population in India

  2012cites this paper
• Host genetic effects on HIV-1 replication in macrophages

  2011cites this paper
• The effecT of TrIm 5 PolymorPhIsms on The clInIcal course of hIV-1 InfecTIon

  2011cites this paper
• Genome-Wide Association Scan in HIV-1-Infected Individuals Identifying Variants Influencing Disease Course

  2011cites this paper
• Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population

  2010cites this paper
• CCR 2-64 I Polymorphism , Syncytium-Inducing Human Immunodeficiency Virus Strains , and Disease Progression

  2010cites this paper
• Cenicriviroc, an orally active CCR5 antagonist for the potential treatment of HIV infection.

  2010cites this paper
• Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.

  2010cites this paper
• Host Genetic Determinants of Human Immunodeficiency Virus Infection and Disease Progression in Children

  2009cites this paper
• Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection

  2009cites this paper
• Human Genetic Factors Involved in Viral Pathogenesis

  2009cites this paper
• The Effect of Trim5 Polymorphisms on the Clinical Course of HIV-1 Infection

  2008cites this paper
• Host Genetic Influences on Highly Active Antiretroviral Therapy Efficacy and AIDS-Free Survival

  2008cites this paper
• CHAPTER 5 – Viral and Host Determinants of HIV-1 Disease Progression

  2008cites this paper
• Tutorial in biostatistics: competing risks and multi‐state models

  2007cites this paper
• CCR2b-64I Allelic Polymorphisms in Advanced HIV-Infected Koreans Accelerate Disease Progression

  2007cites this paper
• Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases.

  2006cites this paper
• Human genetic polymorphisms affecting HIV-1 diseases

  2006cites this paper
• Navratilova POLYMORPHISMS IN CCL 2 & CCL 5 CHEMOKINES / CHEMOKINE RECEPTORS GENES AND THEIR ASSOCIATION WITH DISEASES

  2006cites this paper
• Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the United States.

  2006cites this paper
• Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.

  2005cites this paper
• Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.

  2005cites this paper
• Causal Pathways of the Effects of Age and the CCR5-Δ32, CCR2-64I, and SDF-1 3′A Alleles on AIDS Development

  2005cites this paper
• CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults.

  2004cites this paper
• CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users

  2004cites this paper
• Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour

  2004cites this paper
• The role of polymorphisms in chemokines and chemokine receptors in the clinical course of HIV-1 infection

  2004cites this paper
• Determinants of host HIV-1 suspectibility and R5 HIV-1 evolution

  2004cites this paper
• A CCR2-V64I polymorphism affects stability of CCR2A isoform

  2004cites this paper
• Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection

  2003cites this paper
• Prediction of Residual Time to AIDS and Death Based on Markers and Cofactors

  2003cites this paper
• Early Viral Load and CD4+ T Cell Count, But Not Percentage of CCR5+ or CXCR4+ CD4+ T Cells, Are Associated with R5-to-X4 HIV Type 1 Virus Evolution

  2003cites this paper
• Lack of evidence for an association between a polymorphism in CX3CR1 and the clinical course of HIV infection or virus phenotype evolution.

  2003cites this paper
• Biological and Molecular Aspects of HIV-1 Coreceptor Usage

  2003cites this paper
• Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age

  2003cites this paper
• The impact of human allelic variation on HIV-1 disease.

  2003cites this paper
• Immunopathogenesis of AIDS

  2002cites this paper
• Restricted replication of primary HIV‐1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4+ T cells

  2002cites this paper
• Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load.

  2002cites this paper
• Host Genetic Factors in the Clinical Course of HIV-1 Infection: Chemokines and Chemokine Receptors

  2002cites this paper
• CC chemokine receptor 5 delta 32 and CC chemokine receptor 2 64 I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients

  2002cites this paper
• UvA-DARE (Digital Academic Repository) CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients

  2002cites this paper
• CC Chemokine Receptor 5 Δ32 and CC Chemokine Receptor 2 64I Polymorphisms Do Not Influence the Virologic and Immunologic Response to Antiretroviral Combination Therapy in Human Immunodeficiency Virus Type 1–Infected Patients

  2002cites this paper
• CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.

  2002cites this paper
• Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.

  2001cites this paper
• Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV‐1 plasma RNA viral load and immune activation among HIV‐1 seropositive female workers in Abidjan, Côte d'Ivoire

  2001cites this paper
• No Difference in in Vitro Susceptibility to HIV Type 1 between High-Risk HIV-Negative Ethiopian Commercial Sex Workers and Low-Risk Control Subjects

  2001cites this paper
• Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression

  2001cites this paper
• Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.

  2001cites this paper
• HIV-1 TRANSMISSION

  2000cites this paper
• CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.

  2000cites this paper
• Human I mmunodeficiency Virus S trains, and D isease P rogression

  2000cites this paper
• Some aspects of the natural history of HIV infection

  2000cites this paper
• The effect of genetic variation in chemokines and their receptorson HIV transmission and progression to AIDS

  2000cites this paper
• Prevalence of CCR2-64I, SDF1-3'A and CCR5-Delta32 alleles in healthy Thais.

  2000cites this paper
• Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.

  2000cites this paper
• Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype

  2000cites this paper
• No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.

  1999cites this paper
• CONCISE COMMUNICATIONS Reduced Prevalence of the CCR5 D32 Heterozygous Genotype in Human Immunodeficiency Virus-Infected Individuals with AIDS Dementia Complex

  1999cites this paper
• Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.

  1999cites this paper
• Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.

  1999cites this paper
• Characterization of V3 Sequence Heterogeneity in Subtype C Human Immunodeficiency Virus Type 1 Isolates from Malawi: Underrepresentation of X4 Variants

  1999cites this paper
• CCR 5 delta 32 / + and CCR 2 b 64 I / + mutations on human immunodeficiency virus ( HIV )-1 disease progression among HIV-1-infected injecting drug users

  1999cites this paper
• Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.

  1999cites this paper
• Virus and host determinants of HIV-1 infection and AIDS pathogenesis

  1999cites this paper
• Cc Chemokine Receptor 5 D32 and Cc Chemokine Receptor 2 64i Polymorphisms Do Not Influence the Virologic and Immunologic Response to Antiretroviral Combination Therapy in Human Immunodeficiency Virus Type 1–infected Patients

  year unknowncites this paper